Criterion Capital Advisors’s Organon & Co OGN Stock Holding History

Criterion Capital Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13	Closed	-$188	–	370
2023 Q4	$188	Buy	+13	New	+$177	﹤0.01%	353

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Criterion Capital Advisors's OGN Position: Q1 2024 in Review

Criterion Capital Advisors sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 13 shares — an estimated $188 sold.

Criterion Capital Advisors first reported a position in OGN in Q4 2023 and held it in 1 quarter. The position peaked at $188 in Q4 2023. 721 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

Criterion Capital Advisors reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
Criterion Capital Advisors sold 13 Organon & Co shares in Q1 2024, an estimated $188.
Criterion Capital Advisors first reported a position in Organon & Co in Q4 2023 and held it in 1 quarter.
Criterion Capital Advisors's Organon & Co position peaked at $188 in Q4 2023.
721 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Criterion Capital Advisors's 13F filing for Q1 2024, filed 17 Apr 2024.